Arrythmia
77
17
19
26
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.2%
4 terminated out of 77 trials
86.7%
+0.1% vs benchmark
3%
2 trials in Phase 3/4
15%
4 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 26 completed trials
Clinical Trials (77)
PLAI-AF Trial: Hybrid Endo-epicardial Partial Left Atrial Isolation vs. Endocardial Ablation in Patients With Persistent Atrial Fibrillation
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Parasternal Intercostal Plane Catheter for Pain Control After CABG Surgery
A Usability Study of a Multi-channel ECG Monitoring Device
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery
Sympathetic Activity in Post-injury Outcomes: Impact on Sleep and caRdiovascular Health InvesTigation
Aveir VR Real-World Evidence Post-Approval Study
Aveir DR Real-World Evidence Post-Approval Study
Remote ECG Monitoring Post TAVI
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation
Validation of PET Questionnaire for Experience and Sustainability in Telemedicine. PET(Patient Experience in Telehealth)
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Acute and Chronic Pain After One-stage Hybrid Arrhythmia Ablation Surgery
Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter
Arrhythmias in Post-Myocardial Infarction Patients
Aveir VR Coverage With Evidence Development Post-Approval Study